cholestanol has been researched along with Disease Exacerbation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boscia, A; Corso, G; Dello Russo, A; Di Taranto, MD; Fortunato, G; Gelzo, M; Papagni, F; Sica, C | 1 |
| Cai, YH; Chen, C; Ding, ZT; Gong, LY; Sun, YM; Wang, J; Wu, H; Wu, JJ; Zhang, Y | 1 |
| Björkhem, I; Del Puppo, M; Dotti, MT; Federico, A; Gallus, GN; Magni, A; Mignarri, A | 1 |
| Kato, T; Koyama, S | 1 |
| Barrero, F; Díaz, M; Girós, M; Jiménez-Escrig, A; Lustres, M; Macarrón, J; Pilo de la Fuente, B; Pozo, L; Sobrido, MJ | 1 |
| Campdelacreu, J; Cervera, A; Girós, M; Jaumà, S; Muñoz, E; Tolosa, E | 1 |
| Clemen, CS; Dodel, R; Klockgether, T; Lütjohann, D; Spottke, EA; Urbach, H; von Bergmann, K | 1 |
| Gadoth, N; Meiner, V; Siman-Tov, T | 1 |
1 review(s) available for cholestanol and Disease Exacerbation
| Article | Year |
|---|---|
Pathophysiology of cerebrotendinous xanthomatosis.
Topics: Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestanol; Diagnosis, Differential; Disease Progression; Early Diagnosis; Humans; Mutation; Severity of Illness Index; Xanthomatosis, Cerebrotendinous | 2016 |
7 other study(ies) available for cholestanol and Disease Exacerbation
| Article | Year |
|---|---|
Age-related changes of cholestanol and lathosterol plasma concentrations: an explorative study.
Topics: Adult; Age Factors; Child; Cholestanol; Cholesterol; Disease Progression; Early Diagnosis; Female; Humans; Infant, Newborn; Male; Oxidoreductases Acting on CH-CH Group Donors; Phytosterols; Steroid Metabolism, Inborn Errors; Xanthomatosis, Cerebrotendinous | 2019 |
Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.
Topics: Adult; Age of Onset; Asian People; Cerebellar Ataxia; Cholestanetriol 26-Monooxygenase; Cholestanol; Cognition Disorders; Disease Progression; Female; Genetic Testing; Humans; Male; Middle Aged; Mutation; Paraparesis, Spastic; Pedigree; Polymerase Chain Reaction; Xanthomatosis; Xanthomatosis, Cerebrotendinous | 2017 |
Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
Topics: Adolescent; Adult; Bile Acids and Salts; Biomarkers; Chenodeoxycholic Acid; Cholestanol; Cholestenones; Cholesterol; Disease Progression; Female; Humans; Hydroxycholesterols; Lipid Metabolism; Male; Middle Aged; Prognosis; Xanthomatosis, Cerebrotendinous; Young Adult | 2016 |
[Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis].
Topics: Adolescent; Adult; Age of Onset; Child; Cholestanol; Disease Progression; Humans; Male; Prognosis; Retrospective Studies; Severity of Illness Index; Xanthomatosis, Cerebrotendinous; Young Adult | 2011 |
[Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases].
Topics: Adolescent; Adult; Brain; Child; Cholestanol; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Radiography; Spinal Cord; Xanthomatosis, Cerebrotendinous | 2002 |
Cerebrotendinous xanthomatosis: a treatable ataxia.
Topics: Adult; Cerebellar Ataxia; Cerebellum; Chenodeoxycholic Acid; Cholestanol; Cholesterol; Disease Progression; Electroencephalography; Humans; Magnetic Resonance Imaging; Male; Paraparesis, Spastic; Peripheral Nervous System Diseases; Simvastatin; Treatment Outcome; Xanthomatosis, Cerebrotendinous | 2005 |
Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
Topics: Achilles Tendon; Adult; Brain; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestanol; Cholesterol; Diagnosis, Differential; Diagnostic Errors; Disease Progression; Down-Regulation; Humans; Male; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Simvastatin; Steroid Hydroxylases; Steroids; Treatment Outcome; Up-Regulation; Xanthomatosis, Cerebrotendinous | 2006 |